vs
Side-by-side financial comparison of MODIV INDUSTRIAL, INC. (MDV) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
Spero Therapeutics, Inc. is the larger business by last-quarter revenue ($12.6M vs $11.1M, roughly 1.1× MODIV INDUSTRIAL, INC.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 11.0%, a 239.7% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs -5.6%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs -3.8%).
MODIV INDUSTRIAL, INC. is a U.S.-based industrial real estate enterprise focused on acquiring, owning and operating high-quality industrial properties mainly located in key logistics and distribution hubs across North America. It serves tenants from sectors including e-commerce fulfillment, manufacturing and third-party logistics, addressing rising demand for modern supply chain infrastructure.
MDV vs SPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.1M | $12.6M |
| Net Profit | $1.2M | $31.5M |
| Gross Margin | — | — |
| Operating Margin | 45.8% | — |
| Net Margin | 11.0% | 250.7% |
| Revenue YoY | -5.6% | 24080.8% |
| Net Profit YoY | -22.0% | 250.9% |
| EPS (diluted) | $0.02 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.1M | $12.6M | ||
| Q3 25 | $11.7M | $0 | ||
| Q2 25 | $11.8M | $0 | ||
| Q1 25 | $11.8M | $12.0K | ||
| Q4 24 | $11.7M | $52.0K | ||
| Q3 24 | $11.7M | $65.0K | ||
| Q2 24 | $11.4M | $114.0K | ||
| Q1 24 | $12.0M | $140.0K |
| Q4 25 | $1.2M | $31.5M | ||
| Q3 25 | $1.0M | $-7.4M | ||
| Q2 25 | $-2.0M | $-1.7M | ||
| Q1 25 | $829.0K | $-13.9M | ||
| Q4 24 | $1.6M | — | ||
| Q3 24 | $-587.0K | $-17.1M | ||
| Q2 24 | $1.3M | $-17.9M | ||
| Q1 24 | $3.7M | $-12.7M |
| Q4 25 | 45.8% | — | ||
| Q3 25 | 41.4% | — | ||
| Q2 25 | 9.8% | — | ||
| Q1 25 | 40.2% | -122758.3% | ||
| Q4 24 | 45.4% | — | ||
| Q3 24 | 42.0% | -28604.6% | ||
| Q2 24 | 44.6% | -16720.2% | ||
| Q1 24 | 55.6% | -9987.1% |
| Q4 25 | 11.0% | 250.7% | ||
| Q3 25 | 9.0% | — | ||
| Q2 25 | -17.1% | — | ||
| Q1 25 | 7.0% | -115550.0% | ||
| Q4 24 | 13.3% | — | ||
| Q3 24 | -5.0% | -26380.0% | ||
| Q2 24 | 11.6% | -15668.4% | ||
| Q1 24 | 31.1% | -9049.3% |
| Q4 25 | $0.02 | $0.56 | ||
| Q3 25 | $0.00 | $-0.13 | ||
| Q2 25 | $-0.32 | $-0.03 | ||
| Q1 25 | $-0.01 | $-0.25 | ||
| Q4 24 | $0.07 | — | ||
| Q3 24 | $-0.18 | $-0.32 | ||
| Q2 24 | $0.03 | $-0.33 | ||
| Q1 24 | $0.33 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $14.4M | $40.3M |
| Total DebtLower is stronger | $261.5M | — |
| Stockholders' EquityBook value | $162.7M | $59.0M |
| Total Assets | $476.5M | $68.9M |
| Debt / EquityLower = less leverage | 1.61× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $40.3M | ||
| Q3 25 | $8.3M | $48.6M | ||
| Q2 25 | $5.8M | $31.2M | ||
| Q1 25 | $6.2M | $48.9M | ||
| Q4 24 | $11.5M | $52.9M | ||
| Q3 24 | $6.8M | $76.3M | ||
| Q2 24 | $18.9M | $63.5M | ||
| Q1 24 | $18.4M | $82.3M |
| Q4 25 | $261.5M | — | ||
| Q3 25 | $279.7M | — | ||
| Q2 25 | $279.7M | — | ||
| Q1 25 | $279.7M | — | ||
| Q4 24 | $279.8M | — | ||
| Q3 24 | $279.7M | — | ||
| Q2 24 | $279.7M | — | ||
| Q1 24 | $279.6M | — |
| Q4 25 | $162.7M | $59.0M | ||
| Q3 25 | $164.8M | $26.5M | ||
| Q2 25 | $165.6M | $32.8M | ||
| Q1 25 | $171.1M | $33.8M | ||
| Q4 24 | $190.1M | $46.1M | ||
| Q3 24 | $186.3M | $65.5M | ||
| Q2 24 | $187.0M | $80.5M | ||
| Q1 24 | $188.0M | $96.2M |
| Q4 25 | $476.5M | $68.9M | ||
| Q3 25 | $499.6M | $54.2M | ||
| Q2 25 | $498.9M | $62.1M | ||
| Q1 25 | $506.8M | $77.7M | ||
| Q4 24 | $507.8M | $110.5M | ||
| Q3 24 | $507.4M | $135.2M | ||
| Q2 24 | $519.5M | $149.9M | ||
| Q1 24 | $522.5M | $167.7M |
| Q4 25 | 1.61× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 1.63× | — | ||
| Q4 24 | 1.47× | — | ||
| Q3 24 | 1.50× | — | ||
| Q2 24 | 1.50× | — | ||
| Q1 24 | 1.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $15.0M | $-8.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 12.34× | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.0M | $-8.4M | ||
| Q3 25 | $4.1M | $17.4M | ||
| Q2 25 | $3.9M | $-17.7M | ||
| Q1 25 | $3.0M | $-4.0M | ||
| Q4 24 | $18.2M | $-23.4M | ||
| Q3 24 | $5.1M | $12.8M | ||
| Q2 24 | $4.7M | $-18.7M | ||
| Q1 24 | $3.0M | $5.9M |
| Q4 25 | 12.34× | -0.26× | ||
| Q3 25 | 3.95× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.68× | — | ||
| Q4 24 | 11.72× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.55× | — | ||
| Q1 24 | 0.80× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
